Severe Malaria Observatory
Knowledge sharing for severe malaria
Search
Search
Search
English
\n
Français
\n
Search
Toggle main menu visibility
Severe malaria
What is malaria?
Global burden
Symptoms
Diagnosis
Treatment
Groups at risk
Countries
Angola
Benin
Burkina Faso
Burundi
Cameroon
Central African Republic
Democratic Republic of Congo
Ethiopia
Ghana
Guinea
India
La Cote d'Ivoire
Madagascar
Malawi
Mali
Mozambique
Niger
Nigeria
Rwanda
Senegal
South Sudan
Tanzania
Uganda
Zambia
Drugs & markets
In the field
Severe Malaria Projects
Interviews
Toolkits & training
Injectable artesunate
Artesunate Rectal Capsules
Additional resources
Resources
News & Events
Events
Newsletter
About us
FAQ
Search
Search
Home
Resources
Severe Malaria Resources
1
Keywords
From
From
Year
-Year
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
To
To
Year
-Year
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Year
- Any -
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2008
2007
2005
1982
1981
Tags
- Any -
AQUAMAT
Acceptability
Age
ArTiMist
Asia
Asymptomatic
BCC
Burden
Burkina Faso
CHW
Cameroon
Case Management
Case definition
Central African Republic
Children
Community
Correct use
Correlation
Counterfit
DRC
Delay
Diagnosis
Disease progression
Economics
Ethiopia
Ghana
Haemolysis
ICCM
Immunity
Injectable artemether
Injectable artesunate
Injectable quinine
M&E
MATIAS
Malawi
Manifestations
Mapping
Mixed infections
Mortality
Mozambique
Nigeria
P. Knowlesi
P. Vivax
PNG
Practice
Pre-referral
Rectal artesunate
Referral
Resistance
Senegal
Severity
Stock
Substandard drugs
Sudan
Supply
Tanzania
Training
Travellers
Treatment
Treatment practices
Uganda
Vietnam
WHO
Zambia
care-seeking
Resource type
- Any -
Article
Cochrane review
Guide
Information note
Manual
Peer-reviewed article
Report
Severe malaria rapid assessment reports
Strategy
Survey results
Source
- Any -
25 Apr 2022
Severe Malaria Global Stakeholder Meeting 2022 report
19 Apr 2022
An Optimized Dihydrodibenzothiazepine Lead Compound (SBI-0797750) as a Potent and Selective Inhibitor of Plasmodium falciparum and P. vivax Glucose 6-Phosphate Dehydrogenase 6-Phosphogluconolactonase.
05 Apr 2022
Trends in Pediatric Hospitalizations and Mortality during the COVID-19 Pandemic in an Urban Setting in Cameroon.
05 Apr 2022
Altered Subpopulations of Red Blood Cells and Post-treatment Anemia in Malaria.
04 Apr 2022
ICAM-1
Kilifi
variant is not associated with cerebral and severe malaria pathogenesis in Beninese children.
01 Apr 2022
Pas-de-deux: African Plasmodium falciparum adaptations to sickle hemoglobin.
30 Mar 2022
Malaria Parasitaemia and its Associated Factors among Febrile Children in a Tertiary Hospital in Southwest Nigeria.
29 Mar 2022
Acute kidney injury interacts with coma, acidosis, and impaired perfusion to significantly increase risk of death in children with severe malaria.
28 Mar 2022
A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum.
25 Mar 2022
Role of sphingosine kinase and sphingosine-1-phosphate receptor in the liver pathology of mice infected with Plasmodium berghei ANKA.
24 Mar 2022
Severe Malaria 2022 Stakeholder meeting presentations
18 Mar 2022
Influence of α
2
-Macroglobulin, Anti-Parasite IgM and ABO Blood Group on Rosetting in
Plasmodium falciparum
Clinical Isolates and Their Associations with Disease Severity in a Ghanaian Population.
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »